We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+7%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$263M
AUM Growth
-$4.42M
Cap. Flow
-$7.23M
Cap. Flow %
-2.75%
Top 10 Hldgs %
45.01%
Holding
265
New
72
Increased
63
Reduced
52
Closed
76

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$3.73M
2
MCD icon
McDonald's
MCD
+$3.07M
3
ADI icon
Analog Devices
ADI
+$2.85M
4
WFC icon
Wells Fargo
WFC
+$2.74M
5
MS icon
Morgan Stanley
MS
+$2.6M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$3.81M
2
BAC icon
Bank of America
BAC
+$2.79M
3
VZ icon
Verizon
VZ
+$2.35M
4
PG icon
Procter & Gamble
PG
+$2.07M
5
NEE icon
NextEra Energy
NEE
+$2.03M

Sector Composition

Rank Sector Weight
1 Technology 21.23%
2 Financials 14.68%
3 Healthcare 9.28%
4 Consumer Discretionary 7.05%
5 Industrials 5.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
51
Johnson & Johnson
JNJ
$626B
$970K 0.37%
6,706
+92
+1% +$14.3K
LRCX icon
52
Lam Research
LRCX
$390B
$943K 0.36%
+13,057
New +$990K
CMI icon
53
Cummins
CMI
$87.1B
$941K 0.36%
2,699
+389
+17% +$137K
GM icon
54
General Motors
GM
$78.4B
$938K 0.36%
17,615
+1,319
+8% +$69.1K
BKR icon
55
Baker Hughes
BKR
$64.3B
$937K 0.36%
22,835
-242
-1% -$9.76K
COP icon
56
ConocoPhillips
COP
$151B
$928K 0.35%
9,357
-12
-0.1% -$1.27K
PEP icon
57
PepsiCo
PEP
$189B
$919K 0.35%
6,042
+115
+2% +$18.8K
CFR icon
58
Cullen/Frost Bankers
CFR
$10.3B
$905K 0.34%
6,738
+416
+7% +$54.6K
AMAT icon
59
Applied Materials
AMAT
$417B
$885K 0.34%
5,440
-3,837
-41% -$695K
TXN icon
60
Texas Instruments
TXN
$257B
$883K 0.34%
4,711
-6,151
-57% -$1.23M
MRVL icon
61
Marvell Technology
MRVL
$191B
$874K 0.33%
+7,917
New +$735K
PLTR icon
62
Palantir
PLTR
$420B
$863K 0.33%
+11,413
New +$665K
STT icon
63
State Street
STT
$51.4B
$823K 0.31%
+8,384
New +$794K
CBOE icon
64
Cboe Global Markets
CBOE
$29.5B
$816K 0.31%
4,174
+195
+5% +$40.2K
BSX icon
65
Boston Scientific
BSX
$74.2B
$811K 0.31%
9,078
-1,245
-12% -$110K
APH icon
66
Amphenol
APH
$206B
$811K 0.31%
11,674
-688
-6% -$48.2K
COR icon
67
Cencora
COR
$63.7B
$808K 0.31%
+3,596
New +$846K
STX icon
68
Seagate
STX
$186B
$802K 0.31%
+9,288
New +$935K
UTHR icon
69
United Therapeutics
UTHR
$22.1B
$796K 0.3%
2,255
+163
+8% +$59.9K
UBER icon
70
Uber
UBER
$160B
$793K 0.3%
+13,154
New +$939K
DASH icon
71
DoorDash
DASH
$91.9B
$781K 0.3%
4,658
-1,576
-25% -$259K
OC icon
72
Owens Corning
OC
$12.6B
$780K 0.3%
4,580
+310
+7% +$57.9K
MDB icon
73
MongoDB
MDB
$35.3B
$778K 0.3%
3,343
+518
+18% +$146K
CYBR
74
DELISTED
CyberArk
CYBR
$778K 0.3%
+2,335
New +$710K
DT icon
75
Dynatrace
DT
$14.4B
$776K 0.3%
+14,282
New +$779K

Similar funds

Alpha DNA Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Alpha DNA Investment Management held 265 positions worth $263M, down 1.7% from $267M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Alpha DNA Investment Management's Q4 2024 filing shows 72 new, 63 increased, 52 reduced and 76 closed positions. Its largest new stake was Palo Alto Networks: 6,205 shares worth $1.13M. The largest sale was Walmart Inc, an estimated $3.81M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Alpha DNA Investment Management's largest Q4 2024 buy was Palo Alto Networks: 6,205 shares worth $1.13M.
  • Alpha DNA Investment Management added most to Accenture in Q4 2024, an estimated $3.73M increase.
  • Alpha DNA Investment Management's biggest Q4 2024 reduction was Walmart Inc, cutting an estimated $3.81M.
  • Alpha DNA Investment Management fully exited Verizon in Q4 2024, selling an estimated $2.35M.
  • Alpha DNA Investment Management's ten largest holdings make up 45% of its $263M portfolio in Q4 2024.
  • Alpha DNA Investment Management opened 72 new positions and closed 76 in Q4 2024.
  • Alpha DNA Investment Management's portfolio value fell 1.7% quarter-over-quarter to $263M.

Based on Alpha DNA Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.